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We evaluated quantitative real-time PCR to establish the diagnosis of rotavirus gastroenteritis in a high-disease-burden popula-
tion inMalawi using enzyme immunoassay as the gold standard diagnostic test. In 146 children with acute gastroenteritis and 65
asymptomatic children, we defined a cutoff point in the threshold cycle value (26.7) that predicts rotavirus-attributable gastro-
enteritis in this population. These data will inform the evaluation of direct and indirect rotavirus vaccine effects in Africa.
Rotavirus gastroenteritis is a major cause of infant morbidityand mortality with 90% of rotavirus-associated deaths occur-
ring in low-income settings (1–3). Two live, oral vaccines (Rotarix
[GlaxoSmithKline Biologicals, Belgium] and RotaTeq [Merck &
Co. Inc., USA]) are entering childhood immunization programs
worldwide. These have greatly reduced rotavirus-attributable hos-
pitalizations in high-income and middle-income countries (4, 5),
and a recently published study from Malawi was the first report of
vaccine effectiveness from a low-income country (6).
Laboratory diagnosis of rotavirus gastroenteritis is typically es-
tablished by detection of rotavirus antigen in stool using enzyme-
immunoassay (EIA). This correlates well with clinical disease in
developed settings but is less sensitive than real-time reverse tran-
scription-quantitative PCR (qRT-PCR) (7, 8). However, as qRT-
PCR can detect rotavirus shedding in the stool in up to 30% of
asymptomatic young children in developed settings, the clinical
implications of a positive result is uncertain (9, 10). A positive
relationship between fecal viral load and EIA-positive rotavirus
disease has been demonstrated in children from the United King-
dom and the United States (7, 11) and has been used to define a
quantitative cycle threshold (CT) cutoff point in qRT-PCR corre-
sponding to clinical disease (7, 11).
Much of our understanding of the performance of rotavirus
diagnostic tests comes from well-resourced settings (11–13).
However, rotavirus disease patterns in the poorest settings differ
from those in the developed world, with higher force of infection,
earlier disease onset, and delayed acquisition of immunity, which
may impact diagnosis (14, 15). This study in Blantyre, southern
Malawi, aimed to evaluate the performance of qRT-PCR and EIA
in order to define a cutoff point in the qRT-PCRCT value to define
clinical disease in a high-burden, resource-poor African country
and was undertaken as part of an assessment of monovalent rota-
virus vaccine effectiveness following its introduction into Mal-
awi’s national immunization program in October 2012 (6). Chil-
dren 5 years of age were recruited on presentation to Queen
Elizabeth Central Hospital (QECH) with acute diarrhea (the pas-
sage of three or more loose stools within a 24-h time period within
14 days of presentation). Age- and neighborhood-matched com-
munity controls were enrolled in Blantyre District (6). A single
stool sample was collected from each child and tested for rotavirus
antigen by EIA (Premier Rotaclone; Meridian Biosciences, Cin-
cinnati, OH) without knowledge of clinical status.
Following nucleic acid extraction from 10% to 20% stool sus-
pensions, cDNA was synthesized using random primers. VP6
qRT-PCR was performed using VP6 gene-specific primers and
probes as previously described, using 2TaqMan Universal Mas-
ter Mix II (Invitrogen, Paisley, United Kingdom), and a Rotor-
Gene Q 5-plex system (Qiagen, Manchester, United Kingdom)
(13, 16). A rotavirus qRT-PCR result was deemed positive if theCT
value was40 and negative when the CT value was40.
For amounts of cDNA,30 copies intra-assay reproducibility
was high (Table 1). Samples positive by qRT-PCR that had a CT
value below 11 (n 2) could not be quantified.
Frequency of detection of rotavirus using EIA and qRT-PCR
was described and tested for discordance using McNemar’s test.
Median CT values were compared between EIA-positive (diar-
rhea), EIA-negative (diarrhea), and asymptomatic samples using
Wilcoxon rank sum tests. Receiver operating characteristics
(ROC) analysis was used to evaluate the ability of qRT-PCR CT
values to discriminate between the presence and absence of symp-
tomatic gastroenteritis, using EIA as a gold standard (17, 18) and
defining the absence of disease as EIA negative without diarrhea. A
cutoff point that optimized sensitivity and specificity was identi-
fied using Youden’s index [(sensitivity specificity) 1] (19, 20).
Analysis was conducted using Stata 12.1 (StataCorp, USA) and
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GraphPad Prism 6 (GraphPad Software, Inc., USA). Ethical ap-
proval was provided by the National Health Sciences Research
Committee, Lilongwe, Malawi (867) and by the Research Ethics
Committee of the University of Liverpool, Liverpool, United
Kingdom (000490).
A total of 238 fecal samples were collected. Of these, clinical
data were available for 225. Fourteen community samples were
excluded for intercurrent diarrhea, resulting in 211 samples avail-
able for analysis: 77 EIA-positive diarrheal cases, 69-EIA negative
diarrheal cases, and 65 asymptomatic children. Of the 211 samples
with corresponding clinical data, 77 of the 77 (100%) children
with EIA-positive diarrhea were also qRT-PCR positive and 34
(49.3%) of 69 children with EIA-negative diarrhea were qRT-PCR
positive. Of the 65 asymptomatic community controls, 1 (1.5%)
was EIA positive and 20/65 (30.8%) had virus detected using
qRT-PCR.
There was a significant difference in median qRT-PCR CT val-
ues between EIA-negative diarrheal cases (median, 35.9; inter-
quartile range [IQR], 31.0 to 38.0) and those of EIA-positive di-
arrheal cases (median, 19.5; IQR, 16.9 to 23.3; P  0.001), but
there was no significant difference in CT values between EIA-neg-
ative diarrheal cases and those of asymptomatic community con-
trols (median, 37.1; IQR, 33.4 to 38.6; P  0.375) (Fig. 1 and 2).
Quantitative real-time PCR CT values discriminated well between
the presence and absence of rotavirus gastroenteritis as defined
using EIA, with an area under the curve of 0.96 (95% confidence
interval [CI], 0.93 to 1.00). The point that maximized the Youden
index was at a CT value of 26.7, at which point sensitivity and
specificity were 89% and 95%, respectively (corresponding with
an average cDNA copy number per reaction of 3,000 [95% CI,
2,657 to 3,514]; Table 1).
We have demonstrated differences in CT values between rota-
virus EIA-positive and EIA-negative diarrheal children in a high-
burden, low-resource setting and defined an optimal CT cutoff
point, which may be utilized to diagnose clinical disease as molec-
ular diagnostics are increasingly rolled out in this region. We
found that, consistent with data from the United Kingdom and
the United States, a positive rotavirus EIA result was strongly as-
sociated with the presence of diarrhea, with only one asymptom-
atic, EIA-positive child identified (7, 11). However, qRT-PCR was
more sensitive at detecting rotavirus in stool than EIA (12), with a
high frequency (31%) of low-level viral shedding detected by
qRT-PCR in samples from the asymptomatic group. This con-
firms that detection of rotavirus using qRT-PCR without consid-
eration of viral load is insufficient to attribute disease causation
(11). The prevalence of viral shedding in the asymptomatic group
is high (31%) but is consistent with that found in young children
in the United Kingdom (9).
There were significant differences in the rotavirus CT values
between diarrheal children who were EIA positive and those who
TABLE 1 VP6 qPCR inter-assay reproducibility in eight separate runs
Standard curve
input copy no.
CT value Calculated copy no.
Mean Minimum Maximum Mean %CVa
3,000,000 15.08 14.86 16.35 2,929,261 0.13
300,000 18.91 18.14 19.25 335,457 0.12
30,000 23.34 22.29 24.99 27,236 0.14
3,000 26.85 25.90 27.73 3,320 0.20
300 31.47 30.51 32.88 306 0.20
30 34.94 33.45 35.98 30 0.15
3 38.23 37.27 40 (neg) 4b 0.25b
a CV, coefficient of variation.
b Calculated only for assays in which the result was positive for this sample (40).
FIG 1 Distribution of qRT-PCR CT values between diarrheal cases and asymptomatic controls.
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were EIA negative, with substantially higherCT values (lower viral
load) in children who were EIA negative, and no significant dif-
ference in qRT-PCR CT values between EIA-negative diarrheal
children and those of asymptomatic children. ROC analysis con-
firmed the discriminatory value of qRT-PCRCT values. The cutoff
point in our study is similar to that defined in a United Kingdom
population using the same assay (11), suggesting that any differ-
ence in frequency of infection or in disease severity between the
two settings does not impact distribution of viral loads and that
EIA and qRT-PCR perform similarly in the detection of rotavirus
gastroenteritis in each environment.
Children were recruited from a referral hospital, and a large
number had severe disease. However, the cutoff we identified cor-
relates well with that identified using a cohort of children re-
cruited from primary care in the United Kingdom, in whom less
severe disease should be better represented (11). Moreover, since
reaction sensitivities may vary between PCR assays conducted in
different laboratories, we have provided cDNA copy numbers cor-
responding to the qRT-PCR CT values to facilitate comparison.
Assessment of rotavirus vaccine effectiveness requires accurate
laboratory diagnostics. In high-burden, low-income settings
where direct vaccine effectiveness is lower (6), demonstrating in-
direct (herd) benefits becomes more important. Should rotavirus
vaccine reduce asymptomatic shedding, its impact on community
rotavirus transmission may be substantial. Future evaluation of
vaccine indirect effects will require measurement of impact on
asymptomatic shedding and community transmission using the
cutoffs we have defined in this paper. Our findings, therefore,
inform the evaluation of direct and indirect rotavirus vaccine ef-
fects in Africa.
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